These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26163618)

  • 1. MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.
    Huang HG; Luo X; Wu S; Jian B
    Asian Pac J Cancer Prev; 2015; 16(12):4937-44. PubMed ID: 26163618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
    Hu Y; Zhu Q; Tang L
    PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival.
    Liu Y; Li B; Yang X; Zhang C
    J Cell Biochem; 2019 Dec; 120(12):19330-19337. PubMed ID: 30560585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR.
    Yin H; Ma J; Chen L; Piao S; Zhang Y; Zhang S; Ma H; Li Y; Qu Y; Wang X; Xu Q
    Cell Physiol Biochem; 2018; 46(2):471-481. PubMed ID: 29614485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
    Wu SH; Han L; Lu BC; Wang HY; Zheng CP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development.
    Cheng H; Xue J; Yang S; Chen Y; Wang Y; Zhu Y; Wang X; Kuang D; Ruan Q; Duan Y; Wang G
    Oncotarget; 2017 Jul; 8(29):47984-47997. PubMed ID: 28624790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
    Sun J; Chen Z; Tan X; Zhou F; Tan F; Gao Y; Sun N; Xu X; Shao K; He J
    Med Oncol; 2013 Mar; 30(1):411. PubMed ID: 23292834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long non-coding RNA ANRIL inhibits tumorigenesis in human gastric cancer cells via microRNA-99a-mediated down-regulation of BMI1.
    Liu P; Zhang M; Niu Q; Zhang F; Yang Y; Jiang X
    Braz J Med Biol Res; 2018 Aug; 51(10):e6839. PubMed ID: 30156609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
    He L; Guo S; Zhu T; Chen C; Xu K
    Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
    Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
    Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
    J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.
    Wang B; Wang H; Yang Z
    PLoS One; 2012; 7(10):e47053. PubMed ID: 23056576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.
    Song Y; Dou H; Wang P; Zhao S; Wang T; Gong W; Zhao J; Li E; Tan R; Hou Y
    Cancer Biol Ther; 2014 Oct; 15(10):1423-30. PubMed ID: 25046358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways.
    Li XJ; Luo XQ; Han BW; Duan FT; Wei PP; Chen YQ
    Br J Cancer; 2013 Oct; 109(8):2189-98. PubMed ID: 24030073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.